RxDoctor Payments Data

Daniel Wahl

Radiation Oncology · Ann Arbor, MINPI 1891052262

Payments from drug & device makers

What this record shows

This record is dominated by grants: $36,932 of the $42,390 with a category attached, or 87.1%. Genentech, Inc. accounts for 87.1% of it on its own, with 2 other manufacturers making up the rest. Among radiation oncology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$42,390in general payments, 2019–2025

Across 9 payments — averaging $4709.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$37K
  • Agios Pharmaceuticals, Inc.$5K
  • Boston Scientific$15
$301,072in research payments, 2019–2025

Across 6 payments — averaging $50,179 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Agios Pharmaceuticals, Inc.$301K

What the payments were for

  • Consulting fees$1,9004%
  • Speaking & faculty fees$2,6256%
  • Grants$36,93287%
  • Travel & lodging$8502%
  • Food & beverage$830%

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$42,390 in reported general payments places this provider in the 95th percentile of 198 radiation oncology providers in Michigan.

See all radiation oncology providers in Michigan

Medicare billing

Part B allowed, 2024
$24,167
Medicare patients
33
Services billed
253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →